Back to MORGAN STANLEY MORGAN STANLEY

NRSNNRSN
Showing 6 of 7 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in NEUROSENSE THERAPEUTICS LTD

MORGAN STANLEY previously held 0 shares of NRSN (NEUROSENSE THERAPEUTICS LTD), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.71
0
2025-Q3
Decreased
66,400
-16.9%
$83,0000.0%$1.25
0
2025-Q2
Increased
79,900
+58.2%
$151,0110.0%$1.90
22
2025-Q1
Decreased
50,501
-50.8%
$46,9610.0%$1.00
0
2024-Q4
New
102,581
-
$123,0970.0%$1.24
34
2024-Q3
Exited
0
-100.0%
$00.0%$1.28
0

Other major holders of NRSN: CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Hudson Bay Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used